Clinical Trials Browser

Phase 3 × Leukemia, Myeloid, Chronic-Phase × nilotinib × Clear all

Leukemia, Myeloid, Chronic-Phase

NCT02627677 2021-11-26

OPTIC-2L

Bone Marrow Diseases, Hematologic Diseases, Leukemia, Leukemia, Myeloid, Myeloproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT03079505 2019-01-23

DANIN

Phase 3 Terminated

10 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

Clinical Trials

Nilotinib for First-line Newly Diagnosed CML-CP Patients

OPTIC-2L

DANIN